Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.

Abstract

BACKGROUND Recent genetic studies have implicated p53 mutation as a significant risk factor for therapeutic failure in squamous cell carcinoma of the head and neck (SCCHN). However, in a recent meta-analysis in the literature of p53 from major anatomical subsites (larynx, oral cavity, oropharynx/hypopharynx), associations between patient survival and p53… (More)
DOI: 10.1002/cncr.25864

Topics

Cite this paper

@article{Vlatkovi2011LossOM, title={Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.}, author={Nikolina Vlatkovi{\'c} and Ashraf Y. El-Fert and Timothy Devling and Arpita Ray-Sinha and David Marcus Gore and Carlos P. Rubbi and Andy Dodson and Andrew S. Jones and Tim R Helliwell and Terence M. Jones and Mark T. Boyd}, journal={Cancer}, year={2011}, volume={117 13}, pages={2939-50} }